Vise Technologies’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486K | Buy |
+9,941
| New | +$486K | 0.02% | 660 |
|
|
2024
Q4 | $461K | Sell |
10,215
-672
| -6% | -$30.3K | 0.04% | 462 |
|
|
2024
Q3 | $404K | Sell |
10,887
-3,429
| -24% | -$127K | 0.05% | 360 |
|
|
2024
Q2 | $438K | Buy |
14,316
+1,168
| +9% | +$35.7K | 0.08% | 248 |
|
|
2024
Q1 | $382K | Buy |
13,148
+340
| +3% | +$9.89K | 0.08% | 246 |
|
|
2023
Q4 | $353K | Buy |
12,808
+2,140
| +20% | +$59K | 0.08% | 239 |
|
|
2023
Q3 | $239K | Buy |
10,668
+1,673
| +19% | +$37.5K | 0.06% | 286 |
|
|
2023
Q2 | $366K | Buy |
8,995
+473
| +6% | +$19.2K | 0.09% | 220 |
|
|
2023
Q1 | $413K | Buy |
8,522
+444
| +5% | +$21.5K | 0.11% | 193 |
|
|
2022
Q4 | $308K | Buy |
8,078
+1,306
| +19% | +$49.9K | 0.1% | 230 |
|
|
2022
Q3 | $340K | Buy |
+6,772
| New | +$340K | 0.13% | 195 |
|